Week 1 HW: Final Project Ideas

Biomanufacturing Proposal: Ectoine from a Native Bolivian Salar Extremophile

1. What I would like to biomanufacture and why

I propose to biomanufacture ectoine, a small organic compound known as a compatible solute or osmolyte. Halophilic microorganisms accumulate ectoine intracellularly to survive extreme salinity, and the same molecule has become a high-value ingredient in cosmetics (moisturizers, anti-aging and UV-protection creams) and in pharmaceutical products such as nasal sprays and eye drops, where it stabilizes proteins and cell membranes under stress.

My motivation is to valorize a biological resource that is literally native to Bolivia. The Bolivian Altiplano hosts hypersaline lakes and salt flats (Laguna Colorada, Salar de Uyuni, Salar de Coipasa) with extremophilic bacteria adapted to extreme salinity, alkalinity, and UV exposure at over 4000 meters of altitude. Instead of importing a cosmetic ingredient currently dominated by a handful of manufacturers abroad, this project would build local capacity to produce it from a strain that was isolated, described, and deposited by Bolivian and Bolivia-based researchers. It is worth noting explicitly that I am not proposing polyhydroxybutyrate (PHB) bioplastic production, even though the same genus is well known for it. I am deliberately targeting the osmolyte pathway instead, since it is a lower-volume, higher-value product with a clearer path to a first commercial scale.

2. What living system would I use

The proposed chassis is Halomonas boliviensis, a moderately halophilic, alkalitolerant bacterium isolated from saline soil around Laguna Colorada in southwest Bolivia, and originally described by researchers based at the Centro de Biotecnología of the Universidad Mayor de San Simón (Quillaguamán et al., 2004). The species is already known to accumulate both PHB and ectoine in high yields (Coimbra et al., 2025), so the biology needed for the ectoine pathway is already present; it does not need to be engineered in from scratch.

The process would follow the classic “bacterial milking” scheme: cells are first grown in a high-salt medium (mimicking salar brine conditions), which triggers intracellular ectoine synthesis as an osmotic protectant (Liu et al., 2021). The cells are then subjected to a sudden hypoosmotic shock (rapid dilution into low-salt medium), which causes them to release ectoine into the surrounding liquid without lysing, so the same cell batch can, in principle, be reused for further cycles. Inputs are a carbon source (glucose or a cheaper local substrate), salts, and minerals; outputs are biomass plus an ectoine-rich supernatant, which is then clarified and purified (centrifugation, chromatography, crystallization) into a powder suitable for formulation.

3. How would I use automation

At the strain and process development stage, I would use a desktop liquid-handling robot (an Opentrons-type platform) to run automated screening across a matrix of NaCl concentrations and downshock timings in 96-well format, and to compare H. boliviensis against other candidate isolates collected from different Bolivian salars, with automated OD600 and sampling to identify the best-performing condition and strain without manual pipetting error.

At the production stage, I would automate the bioreactor’s feed and milking steps: programmable pumps to maintain the high-salt growth phase, in-line conductivity and OD sensors to detect when cells reach peak ectoine accumulation, and a programmed rapid-dilution step to trigger the osmotic downshock at a consistent, reproducible point in the cycle. This is the step most worth automating, since manual timing of the shock is a known source of batch-to-batch variability in the milking process.

4. How much would I need to make, and how long would it take

(a) How much

Global demand for ectoine is estimated at approximately 15,000 metric tons per year, at a market price of roughly 1000 USD per kilogram (Liu et al., 2021). Production today is dominated by a small number of large producers whose output still falls short of demand. As a first, realistic target, I define a scale of 1000 kg (1 metric ton) of ectoine per year, roughly 0.007 percent of global demand: a small but credible entry volume for a first pilot-to-early-commercial line rather than an attempt to meet global demand outright.

(b) How long

For H. boliviensis LC1, a two-step fed-batch culture and milking process has been reported to reach a volumetric productivity of about 0.14 g of ectoine per liter per hour (Van-Thuoc et al., 2010, as also reported in Coimbra et al., 2025). Assuming, as a working assumption not yet verified, that this volumetric productivity holds when scaled to a 1000-liter pilot reactor:

1000 L x 0.14 g/(L·h) = 140 g/h ≈ 3360 g/day (continuous operation)

Over roughly 300 operating days a year (allowing for cleaning, maintenance, and cycle changeovers), one 1000-L reactor would yield about 1008 kg/year, meeting the 1-ton target within roughly one year of continuous operation with a single pilot-scale bioreactor.

5. What I don’t know yet

Whether H. boliviensis, or other unstudied isolates from the Bolivian salars themselves (Uyuni, Coipasa), actually reach competitive ectoine titers once the milking step specifically (not just total fermentation titer) is measured; this needs direct experimental testing.
How well the strain tolerates repeated milking cycles (repeated osmotic downshocks) without losing viability or productivity, since this is not yet characterized for this species and directly determines the true cost per kilogram.
Whether the assumed volumetric productivity actually holds at pilot scale (1000 L) and under Bolivian high-altitude operating conditions, where lower atmospheric pressure affects oxygen transfer in aerobic fermentation; this would require a pilot run to confirm.

References

Coimbra, A. A. B., Prakash, S., Jiménez, J. I., & Rios-Solis, L. (2025). Establishing Halomonas as a chassis for industrial biotechnology: advances in synthetic biology tool development and metabolic engineering strategies. Microbial Cell Factories. https://doi.org/10.1186/s12934-025-02757-2

Liu, M., Liu, H., Shi, M., Jiang, M., Li, L., & Zheng, Y. (2021). Microbial production of ectoine and hydroxyectoine as high-value chemicals. Microbial Cell Factories, 20, 76. https://doi.org/10.1186/s12934-021-01567-6

Ma, Z., Wu, C., Zhu, L., Chang, R., Ma, W., Deng, Y., & Chen, X. (2022). Bioactivity profiling of the extremolyte ectoine as a promising protectant and its heterologous production. 3 Biotech, 12, Article 331. https://doi.org/10.1007/s13205-022-03370-5

Quillaguamán, J., Hatti-Kaul, R., Mattiasson, B., Alvarez, M. T., & Delgado, O. (2004). Halomonas boliviensis sp. nov., an alkalitolerant, moderate halophile isolated from soil around a Bolivian hypersaline lake. International Journal of Systematic and Evolutionary Microbiology, 54(3), 721-725. https://doi.org/10.1099/ijs.0.02800-0

Van-Thuoc, D., Guzmán, H., Quillaguamán, J., & Hatti-Kaul, R. (2010). High productivity of ectoines by Halomonas boliviensis using a combined two-step fed-batch culture and milking process. Journal of Biotechnology, 147(1), 46-51. https://doi.org/10.1016/j.jbiotec.2010.03.003

AI Usage Disclosure

Claude was used to help clarify and organize ideas, to search for and verify the supporting literature.